Core Scientific, Inc./tx (CORZZ) EBT (2020 - 2026)

Core Scientific (CORZZ) has 7 years of EBT data on file, last reported at -$346.6 million in Q1 2026.

• For the quarter ending Q1 2026, EBT fell 160.12% year-over-year to -$346.6 million; the trailing twelve-month figure through Mar 2026 stood at -$1.2 billion (down 13.03% YoY), and the FY2025 full-year result was -$288.0 million, up 79.96% from the prior year.
• EBT fell to -$346.6 million in Q1 2026, from $216.1 million in the prior quarter.
• In the past five years, EBT ranged from a high of $576.5 million in Q1 2025 to a low of -$936.6 million in Q2 2025.
• A 5-year average of -$263.6 million and a median of -$290.8 million in 2024 frame the typical range for EBT.
• Across the five-year window, EBT sank 25965.69% in 2022 and soared 74359.51% in 2024, its largest moves.
• Tracing CORZZ's EBT over 5 years: stood at -$456.3 million in 2022, then soared by 57.19% to -$195.4 million in 2023, then plunged by 48.84% to -$290.8 million in 2024, then soared by 174.3% to $216.1 million in 2025, then plunged by 260.42% to -$346.6 million in 2026.
• Business Quant data shows CORZZ's EBT at -$346.6 million in Q1 2026, $216.1 million in Q4 2025, and -$143.9 million in Q3 2025.